Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.19.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.479EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.625EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.332EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.1.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ES.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.373EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.242EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.449EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.152EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.146EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used